Acquisition by Ryan Watts of 89520 shares of Denali Therapeutics subject to Rule 16b-3
DNLI Stock | USD 19.30 0.99 5.41% |
Under 61% of all Denali Therapeutics' traders are looking to take a long position. The analysis of overall sentiment of trading Denali Therapeutics stock suggests that some investors are interested at this time. Denali Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Denali Therapeutics. The current market sentiment, together with Denali Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Denali Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Denali Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Denali daily returns and investor perception about the current price of Denali Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Denali |
Filed transaction by Denali Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Denali Therapeutics Fundamental Analysis
We analyze Denali Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Denali Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Denali Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Denali Therapeutics is currently under evaluation in book value per share category among related companies. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Denali Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Denali Therapeutics stock to make a market-neutral strategy. Peer analysis of Denali Therapeutics could also be used in its relative valuation, which is a method of valuing Denali Therapeutics by comparing valuation metrics with similar companies.
Peers
Denali Therapeutics Related Equities
HOWL | Werewolf Therapeutics | 11.88 | ||||
RNA | Avidity BiosciencesInc | 4.11 | ||||
TVTX | Travere Therapeutics | 4.10 | ||||
SWTX | SpringWorks Therapeutics | 3.67 | ||||
GLUE | Monte Rosa | 2.06 | ||||
AKRO | Akero Therapeutics | 1.94 | ||||
STOK | Stoke Therapeutics | 0.61 | ||||
PCVX | VaxcyteInc | 0.53 | ||||
DAWN | Day One | 0.31 | ||||
CERE | Cerevel Therapeutics | 0.02 | ||||
RVMD | Revolution Medicines | 0.03 | ||||
BGNE | BeiGene | 0.23 | ||||
DSGN | Design Therapeutics | 0.44 | ||||
FDMT | 4D Molecular | 0.51 | ||||
IKNA | Ikena Oncology | 0.76 | ||||
ASND | Ascendis Pharma | 1.08 | ||||
BPMC | Blueprint Medicines | 1.18 | ||||
LEGN | Legend BiotechCorp | 1.63 | ||||
APLS | Apellis Pharmaceuticals | 2.05 | ||||
BDTX | Black Diamond | 2.78 |
Check out Denali Therapeutics Hype Analysis, Denali Therapeutics Correlation and Denali Therapeutics Performance. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.